Effect of raloxifene on sexual function in older postmenopausal women with osteoporosis

Obstetrics and Gynecology

Volumn 101, Issue 2, 2003, Pages 353-361

  Modugno, Francesmary ^a,b   Ness, Roberta B ^a,b   Ewing, Susan ^a,b   Cauley, Jane A ^a,b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RALOXIFENE;

ADULT; AGED; ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LIBIDO; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORGASM; OUTCOMES RESEARCH; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SATISFACTION; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PROBABILITY; RALOXIFENE; REFERENCE VALUES; RISK ASSESSMENT; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SEXUALITY; TREATMENT OUTCOME;

EID: 0037311197     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02589-9     Document Type: Article

References (47)

1. Dennerstein L., Dudley E., Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril. 76:2001;456-460.
2. McCoy N., Davidson J. A longitudinal study of the effects of menopause on sexuality. Maturitas. 7:1985;203-210.
3. Dennerstein L., Dudley E.C., Hopper J.L., Burger H. Sexuality, hormones and the menopausal transition. Maturitas. 26:1997;83-93.
4. Frank E., Anderson C., Rubinstein D. Frequency of sexual dysfunction in "normal" couples. N Engl J Med. 299:1978;111-115.
5. Leiblum S., Bachmann G., Kemmann E., Colburn D., Swartzman L. Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones. JAMA. 249:1983;2195-2198.
6. Semmens J.P., Wagner G. Estrogen deprivation and vaginal function in postmenopausal women. JAMA. 248:1982;445-448.
7. Steger R.W., Hafez E.S.E. Age associated changes in the vagina. Hafez E.S.E. The human vagina. 1977;Elsevier/North Holland, New York.
8. Dennerstein L., Burrows G.D., Wood C., Hyman G. Hormones and sexuality Effect of estrogen and progestogen . Obstet Gynecol. 56:1980;316-322.
9. Campbell S. Double blind psychometric studies on the effects of natural estrogens on postmenopausal women. Campbell S. The management of menopause and postmenopausal years. 1976;MTP Press, Lancaster, UK.
10. Utian W.H. The true clinical features of postmenopause and oophorectomy, and their response to estrogen therapy. S Afr Med J. 46:1972;732-737.
11. Wren B.G., Brown L.B., Routledge D.A. Differential clinical response to estrogens after menopause. Med J Aust. 2:1982;329-332.
12. Hlatky M.A., Boothroyd D., Vittinghoff E., Sharp P., Whooley M.A., Heart P.H.R. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy Results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial . JAMA. 287:2002;591-597.
13. Geola F.L., Frumar A.M., Tataryn I.V., Lu K.H., Hershman J.M., Eggena P., et al. Biological effects of various doses of conjugated equine estrogens in postmenopausal women. Clin Endocrinol Metab. 51:1980;620-625.
14. Chetkowski R.J., Meldrum D.R., Steingold K.A., Randle D., Lu J.K., Eggena P., et al. Biologic effects of transdermal estradiol. N Engl J of Med. 19:(314):1986;1615-1620.
15. Fedor-Freybergh P. The influence of estrogens on the wellbeing and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand Suppl. 64:1977;1-91.
16. Dow M.G., Hart D.M., Forrest C.A. Hormonal treatments of sexual unresponsiveness in postmenopausal women A comparative study . Br J Obstet Gynaecol. 90:1983;361-366.
17. Paterson M.E. A randomised, double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climacteric symptoms and biochemical parameters. Maturitas. 4:1982;83-94.
18. Sherwin B.B., Gelfand M.M., Brender W. Androgen enhances sexual motivation in females A prospective, cross-over study of sex steroid administration in the surgical menopause . Psychosom Med. 47:1985;339-351.
19. Sherwin B.B., Gelfand M.M. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med. 49:1987;397-409.
20. Brincat M., Magos A., Studd J.W., Cardozo L.D., O'Dowd T., Wardle P.J., et al. Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study. Lancet. 1:1984;16-18.
21. Burger H., Hailes J., Nelson J., Menelaus M. Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women. Br Med J (Clin Res Ed). 294:1987;936-937.
22. Ettinger B., Black D.M., Mitlak B.H., Knickerbocker R.K., Nickelsen T., Genant H.K., et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators . JAMA. 282:1999;637-645.
23. Walsh B.W., Kuller L.H., Wild R.A., Paul S., Farmer M., Lawrence J.B. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA. 279:1998;1445-1451.
24. Delmas P.D., Bjarnason N.H., Mitlak B.H., Ravoux A.C., Shah A.S., Huster W.J., et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med. 337:1997;1641-1647.
25. Draper M.W., Flowers D.E., Huster W.J., Neild J.A., Harper K.D., Arnaud C. A controlled trial of raloxifene (LY139481) HCl Impact on bone turnover and serum lipid profile in healthy postmenopausal women . J Bone Miner Res. 11:1996;835-842.
26. Cummings S.R., Eckert S., Krueger K.A., Grady D., Powles T.J., Cauley J.A., et al. The effect of raloxifene on risk of breast cancer in postmenopausal women Results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation . JAMA. 281:1999;2189-2197.
27. Khovidhunkit W., Shoback D.M. Clinical effects of raloxifene hydrochloride in women. Ann Intern Med. 130:1999;431-439.
28. Strickler R., Stovall D.W., Merritt D., Shen W., Wong M., Silfen S. Raloxifene and estrogen effects on quality of life in healthy postmenopausal women A placebo-controlled randomized trial . Obstet Gynecol. 96:2000;359-365.
29. Draper M., Flowers D., Huster W.J., Neild J.A., Harper K.D., Arnaud C.L.A.U. A controlled trial of raloxifene (LY139481) HCl Impact on bone turnover and serum lipid profile in healthy postmenopausal women . J Bone Miner Res. 11:1996;835-842.
30. Delmas P.D., Bjarnason N.H., Mitlak B.H., Ravoux A.C., Shah A.S., Huster W.J., et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med. 337:1997;1641-1647.
31. Cohen F.J., Lu Y. Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials. Maturitas. 34:1999;65-73.
32. Parsons A.K., Nachtigall L.E., Merritt D., Basson R., Heath H., Plouffe L. Vaginal premarin vs. replens in women with pre-existing vaginal atrophy receiving oral placebo or raloxifene Effects on objective endpoints . Menopause. 6:1999;341.
33. Parsons A.K., Nachtigall L.E., Sulak P., Basson R., Heath H., Plouffe L. Vaginal premarin vs. replens in women with pre-existing vaginal atrophy receiving oral placebo or raloxifene Effects on subjective endpoints . Menopause. 6:1999;340.
34. Cohen J. Statistical power analysis for the behavioral sciences. 1988;Lawrence Erlbaum Associates, Mahwah, New Jersey.
35. Mourits M.J., De Vries E.G., Willemse P.H., Ten Hoor K.A., Hollema H., Van der Zee A.G. Tamoxifen treatment and gynecologic side effects A review . Obstet Gynecol. 97:2001;855-866.
36. Day R., Ganz P.A., Costantino J.P., Cronin W.M., Wickerham D.L., Fisher B. Health related quality of life and tamoxifen in breast cancer prevention A report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study . J Clin Oncol. 19:1999;2659-2669.
37. Fallowfield L., Fleissig A., Edwards R., West A., Powles T.J., Howell A., et al. Tamoxifen for the prevention of breast cancer Psychosocial impact on women participating in two randomized controlled trials . J Clin Oncol. 19:2001;1885-1892.
38. Boccardo F., Bruzzi P., Rubagotti A., Nicolo G.U., Rosso R. Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology. 38:1981;281-285.
39. Ferrazzi E., Cartei G., Mattarazzo R., Fiorentino M. Oestrogen-like effect of tamoxifen on vaginal epithelium. BMJ. 1:1977;1351-1352.
40. Mortimer J.E., Boucher L., Baty J., Knapp D.L., Ryan E., Rowland J.H. Effect of tamoxifen on sexual functioning in patients with breast cancer. J Clin Oncol. 17:1999;1488-1492.
41. Diokno A.C., Brown M.B., Herzog A.R. Sexual function in the elderly. Arch Intern Med. 150:1990;197-200.
42. Hunter M.S. Psychological and somatic experience of the menopause A prospective study . Psychosom Med. 52:1990;357-367.
43. Hunter M.S., Battersby R., Whitehead M. Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas. 8:1986;217-218.
44. Osborn M., Hawton K., Gath D. Sexual dysfunction among middle aged women in the community. Br Med J (Clin Res Ed). 296:1988;959-962.
45. Hawton K., Gath D., Day A. Sexual function in a community sample of middle-aged women with partners Effects of age, marital, socioeconomic, psychiatric, gynecological, and menopausal factors . Arch Sex Behav. 23:1994;375-395.
46. Female sexual dysfunction: Clinical development of drug products for treatment. 2000;U.S. Department of Health and Human Services, Rockville, MD.
47. Kanis J.A., Melton L.J., Christiansen C., Johnston C.C., Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 9:1994;1137-1141.